Latest News about SNY
Recent news which mentions SNY
   Earnings Scheduled For October 28, 2022
   
  
  
  October 28, 2022
  From Benzinga
 Tickers 
   SNY
  
  
  From MarketWatch
 From Motley Fool
 
   US Stock Futures Lower Following Friday's Rally; Tesla In Focus
   
  
  
  October 24, 2022
  From Benzinga
 
   New Drugs Approvals Bring No Relief for Ailing Innovent Bio
   
  
  
  October 18, 2022
  From Benzinga
 From Motley Fool
 
   3 Red-Hot Stocks That Could Continue to Beat the Market
   
  
  
  October 13, 2022
  From Motley Fool
 From Benzinga
 
   2 Top Healthcare Stocks to Buy Right Now
   
  
  
  October 08, 2022
  From Motley Fool
 
   7 Under-$50 Stocks to Buy to Tap Into a Hidden Bull Market
   
  
  
  October 07, 2022
  From InvestorPlace
 
   Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate
   
  
  
  October 06, 2022
  From Benzinga
 From Motley Fool
 
   Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
   
  
  
  September 29, 2022
  From Benzinga
 
   Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
   
  
  
  September 20, 2022
  From Benzinga
 
   Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger
   
  
  
  September 19, 2022
  From Benzinga
 
   2 Biotech Stocks You Can Buy and Hold for the Next Decade
   
  
  
  September 19, 2022
  From Motley Fool
 
   AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
   
  
  
  September 16, 2022
  From Benzinga
 From Benzinga
 
   What's Moderna's Next Billion-Dollar Market? The Answer May Surprise You.
   
  
  
  September 14, 2022
  From Motley Fool
 
   Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
   
  
  
  September 08, 2022
  From Benzinga
 
   Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
   
  
  
  September 06, 2022
  From Benzinga
 
   Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
   
  
  
  September 06, 2022
  From Benzinga
 From Benzinga
 
   Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
   
  September 01, 2022
  Tickers 
   SNY
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
